SMAD2 and neoplasm: However, deletion of a number of key TGFβ signaling components (e.g., TGFβ1, TGFBR1, SMAD2/3, and SMAD4) alone in the ovary does not induce tumor formation [16–19], challenging TGFβ signaling as essential tumor suppressor in the ovary.